50 related articles for article (PubMed ID: 35534113)
1. Molecular dynamics simulations reveal the effect of mutations in the RING domains of BRCA1-BARD1 complex and its relevance to the prognosis of breast cancer.
Kiewhuo K; Priyadarsinee L; Sarma H; Sastry GN
J Biomol Struct Dyn; 2023; 41(22):12734-12752. PubMed ID: 36775657
[TBL] [Abstract][Full Text] [Related]
2. BRCA1-BARD1 promotes RAD51-mediated homologous DNA pairing.
Zhao W; Steinfeld JB; Liang F; Chen X; Maranon DG; Jian Ma C; Kwon Y; Rao T; Wang W; Sheng C; Song X; Deng Y; Jimenez-Sainz J; Lu L; Jensen RB; Xiong Y; Kupfer GM; Wiese C; Greene EC; Sung P
Nature; 2017 Oct; 550(7676):360-365. PubMed ID: 28976962
[TBL] [Abstract][Full Text] [Related]
3. Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms.
Stewart MD; Duncan ED; Coronado E; DaRosa PA; Pruneda JN; Brzovic PS; Klevit RE
Protein Sci; 2017 Mar; 26(3):475-483. PubMed ID: 27977889
[TBL] [Abstract][Full Text] [Related]
4. RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination.
Zhu Q; Huang J; Huang H; Li H; Yi P; Kloeber JA; Yuan J; Chen Y; Deng M; Luo K; Gao M; Guo G; Tu X; Yin P; Zhang Y; Su J; Chen J; Lou Z
Nat Commun; 2021 Nov; 12(1):6653. PubMed ID: 34789768
[TBL] [Abstract][Full Text] [Related]
5. Identification of functional SNPs in BARD1 gene and in silico analysis of damaging SNPs: based on data procured from dbSNP database.
Alshatwi AA; Hasan TN; Syed NA; Shafi G; Grace BL
PLoS One; 2012; 7(10):e43939. PubMed ID: 23056176
[TBL] [Abstract][Full Text] [Related]
6. SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation.
Minten EV; Kapoor-Vazirani P; Li C; Zhang H; Balakrishnan K; Yu DS
Cell Rep; 2021 Mar; 34(13):108921. PubMed ID: 33789098
[TBL] [Abstract][Full Text] [Related]
7. Structural analysis of BRCA1 reveals modification hotspot.
Liang Y; Dearnaley WJ; Varano AC; Winton CE; Gilmore BL; Alden NA; Sheng Z; Kelly DF
Sci Adv; 2017 Sep; 3(9):e1701386. PubMed ID: 28948225
[TBL] [Abstract][Full Text] [Related]
8. BRCA1/BARD1 intrinsically disordered regions facilitate chromatin recruitment and ubiquitylation.
Witus SR; Tuttle LM; Li W; Zelter A; Wang M; Kermoade KE; Wilburn DB; Davis TN; Brzovic PS; Zhao W; Klevit RE
EMBO J; 2023 Aug; 42(15):e113565. PubMed ID: 37305927
[TBL] [Abstract][Full Text] [Related]
9. The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.
Wu-Baer F; Ludwig T; Baer R
Mol Cell Biol; 2010 Jun; 30(11):2787-98. PubMed ID: 20351172
[TBL] [Abstract][Full Text] [Related]
10. BRCA1-BARD1 combines multiple chromatin recognition modules to bridge nascent nucleosomes.
Burdett H; Foglizzo M; Musgrove LJ; Kumar D; Clifford G; Campbell LJ; Heath GR; Zeqiraj E; Wilson MD
Nucleic Acids Res; 2023 Nov; 51(20):11080-11103. PubMed ID: 37823591
[TBL] [Abstract][Full Text] [Related]
11. The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection.
Billing D; Horiguchi M; Wu-Baer F; Taglialatela A; Leuzzi G; Nanez SA; Jiang W; Zha S; Szabolcs M; Lin CS; Ciccia A; Baer R
Mol Cell; 2018 Oct; 72(1):127-139.e8. PubMed ID: 30244837
[TBL] [Abstract][Full Text] [Related]
12. Docking and Molecular Dynamics Simulation Revealed the Potential Inhibitory Activity of Amygdalin in Triple-Negative Breast Cancer Therapeutics Targeting the BRCT Domain of BARD1 Receptor.
Chatterjee P; Karn R; Emerson IA; Banerjee S
Mol Biotechnol; 2024 Apr; 66(4):718-736. PubMed ID: 36732462
[TBL] [Abstract][Full Text] [Related]
13. Literature Review of
Alenezi WM; Fierheller CT; Recio N; Tonin PN
Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32726901
[TBL] [Abstract][Full Text] [Related]
14. The BARD1 C-terminal domain structure and interactions with polyadenylation factor CstF-50.
Edwards RA; Lee MS; Tsutakawa SE; Williams RS; Nazeer I; Kleiman FE; Tainer JA; Glover JN
Biochemistry; 2008 Nov; 47(44):11446-56. PubMed ID: 18842000
[TBL] [Abstract][Full Text] [Related]
15. Structural dynamics of clinically-reported VUS in the BARD1 ARD-BRCT region to predict the molecular basis of alterations.
Barua SA; Choudhary RK; Gawde J; Mishra N; Varma AK
J Biomol Struct Dyn; 2024 Jul; 42(11):5475-5484. PubMed ID: 37418175
[TBL] [Abstract][Full Text] [Related]
16. Inter-BRCT linker is probably the most intolerant region of the BRCA1 BRCT domain.
Yadegari F; Farahmand L; Esmaeili R; Zarinfam S; Majidzadeh-A K
J Biomol Struct Dyn; 2024 Jul; 42(11):5734-5746. PubMed ID: 37948190
[TBL] [Abstract][Full Text] [Related]
17. OLA1 in centrosome biology alongside the BRCA1/BARD1 complex: looking beyond centrosomes.
Gomez V; Hergovich A
Mol Cell; 2014 Jan; 53(1):3-5. PubMed ID: 24411079
[TBL] [Abstract][Full Text] [Related]
18. BARD1 deletion in a patient with suspected hereditary colorectal cancer.
Takaiso N; Imoto I; Yoshimura A; Ouchi A; Komori K; Iwata H; Shimizu Y
Hum Genome Var; 2024 Mar; 11(1):11. PubMed ID: 38485918
[TBL] [Abstract][Full Text] [Related]
19. Computational structural assessment of BReast CAncer type 1 susceptibility protein (BRCA1) and BRCA1-Associated Ring Domain protein 1 (BARD1) mutations on the protein-protein interface.
Thirumal Kumar D; Udhaya Kumar S; Jain N; Sowmya B; Balsekar K; Siva R; Kamaraj B; Sidenna M; George Priya Doss C; Zayed H
Adv Protein Chem Struct Biol; 2022; 130():375-397. PubMed ID: 35534113
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
